Inspire Medical Systems reported an 84% year-over-year revenue increase in Q1 2023, reaching $127.9 million. The company expanded its reach with new centers and sales territories, while also achieving key milestones such as FDA approval for pediatric patients with Down syndrome and countrywide reimbursement in Belgium. They are raising their full year 2023 revenue guidance to between $580 million to $590 million.